Healthcare Cold Chain Third Party Logistics Market 2030: Meeting Rising Vaccine Demand
The global healthcare cold chain third-party logistics market was valued at USD 42.75 billion in 2024 and is projected to reach USD 66.12 billion by 2030 , exhibiting a CAGR of 7.6% from 2025 to 2030 . Market growth is primarily driven by the increasing demand for temperature-sensitive pharmaceuticals, heightened regulatory requirements for drug handling, and the expanding distribution of biologics and vaccines worldwide. The rising trend of outsourcing logistics functions by pharmaceutical manufacturers continues to support market expansion. The growing consumption of biologics, vaccines, and other temperature-sensitive medications has significantly increased the need for highly reliable cold chain logistics solutions. Many biologics—such as monoclonal antibodies, recombinant proteins, and gene therapies—require strict temperature control ranging from 2°C to 8°C , while others demand ultra-low storage temperatures of –70°C or below to preserve product ...